Cargando…
Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre
Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315212/ https://www.ncbi.nlm.nih.gov/pubmed/36543220 http://dx.doi.org/10.1055/a-1976-9694 |
_version_ | 1785067467683397632 |
---|---|
author | Krauss, Christian Wagner, Steffen Klußmann, Jens-Peter Pons-Kühnemann, Jörn Arens, Christoph Langer, Christine Wittekindt, Claus |
author_facet | Krauss, Christian Wagner, Steffen Klußmann, Jens-Peter Pons-Kühnemann, Jörn Arens, Christoph Langer, Christine Wittekindt, Claus |
author_sort | Krauss, Christian |
collection | PubMed |
description | Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosis period 1972–2014) were retrospectively collected and analyzed with regard to the distribution of risk factors and their influence on overall survival (OS). Results 19/24 (79.2%) of the subtypes listed in the WHO classification occurred rarely in the cohort (< 5%). 10/24 (41.7%) of all subtypes were never diagnosed. With a total of 145/205 cases (70.7%), squamous cell carcinoma (PEC), adenocarcinoma (AdenoCa), acinar cell carcinoma (AcinarCa), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) were by far the most common subtypes. Risk factors are significantly different in these groups (e.g., lymphogenic metastasis and degree of differentiation in AdenoCa and age, T and UICC stage in PEC). The 5-year overall survival of all patients was 66.9% and differed significantly within the most common subtypes. An independent impact on overall survival was detectable for patient age (p<0.001), and T- (p=0.003) and N-stage (p=0.046) in multivariate analysis. Conclusions Most subtypes occurred markedly rarely or not at all within decades. The most common diagnoses differ with respect to risk factors as well as OS and 3 risk groups can be defined based on histology. In conclusion, considering TNM alone is insufficient for prognosis estimation in salivary gland carcinoma. |
format | Online Article Text |
id | pubmed-10315212 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-103152122023-07-03 Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre Krauss, Christian Wagner, Steffen Klußmann, Jens-Peter Pons-Kühnemann, Jörn Arens, Christoph Langer, Christine Wittekindt, Claus Laryngorhinootologie Objective Salivary gland carcinomas are rare and heterogeneous. More than 20 subtypes are recognized and risk factors are diverse. The aim of this work was to evaluate the subtype and other risk factors in a monocentric population from more than four decades. Material and Methods 205 cases (diagnosis period 1972–2014) were retrospectively collected and analyzed with regard to the distribution of risk factors and their influence on overall survival (OS). Results 19/24 (79.2%) of the subtypes listed in the WHO classification occurred rarely in the cohort (< 5%). 10/24 (41.7%) of all subtypes were never diagnosed. With a total of 145/205 cases (70.7%), squamous cell carcinoma (PEC), adenocarcinoma (AdenoCa), acinar cell carcinoma (AcinarCa), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC) were by far the most common subtypes. Risk factors are significantly different in these groups (e.g., lymphogenic metastasis and degree of differentiation in AdenoCa and age, T and UICC stage in PEC). The 5-year overall survival of all patients was 66.9% and differed significantly within the most common subtypes. An independent impact on overall survival was detectable for patient age (p<0.001), and T- (p=0.003) and N-stage (p=0.046) in multivariate analysis. Conclusions Most subtypes occurred markedly rarely or not at all within decades. The most common diagnoses differ with respect to risk factors as well as OS and 3 risk groups can be defined based on histology. In conclusion, considering TNM alone is insufficient for prognosis estimation in salivary gland carcinoma. Georg Thieme Verlag KG 2022-12-21 /pmc/articles/PMC10315212/ /pubmed/36543220 http://dx.doi.org/10.1055/a-1976-9694 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Krauss, Christian Wagner, Steffen Klußmann, Jens-Peter Pons-Kühnemann, Jörn Arens, Christoph Langer, Christine Wittekindt, Claus Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title | Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title_full | Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title_fullStr | Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title_full_unstemmed | Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title_short | Speicheldrüsenkarzinome – Monozentrische Erfahrung zu Subtypen und deren Inzidenz über 42 Jahre |
title_sort | speicheldrüsenkarzinome – monozentrische erfahrung zu subtypen und deren inzidenz über 42 jahre |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315212/ https://www.ncbi.nlm.nih.gov/pubmed/36543220 http://dx.doi.org/10.1055/a-1976-9694 |
work_keys_str_mv | AT krausschristian speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT wagnersteffen speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT klußmannjenspeter speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT ponskuhnemannjorn speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT arenschristoph speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT langerchristine speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre AT wittekindtclaus speicheldrusenkarzinomemonozentrischeerfahrungzusubtypenunddereninzidenzuber42jahre |